Technical Analysis for MDP - Medexus Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade D 3.95 10.64% 0.380
MDP closed up 10.64 percent on Tuesday, February 18, 2020, on 1.77 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Earnings due: Feb 19
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical MDP trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Above Upper BB Strength 0.00%
20 DMA Resistance Bearish 10.64%
50 DMA Resistance Bearish 10.64%
Shooting Star Candlestick Bearish 10.64%
Outside Day Range Expansion 10.64%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Medexus Pharmaceuticals Inc, formerly Pediapharm Inc, is a Canada-based company engaged in pharmaceutical business sector. The Company is a North American focused, specialty pharmaceutical business that operates through three segments: Medac Pharma USA, a fully integrated commercial infrastructure focused on auto-immune diseases in the United States; Medexus Pharma Canada, a fully integrated commercial infrastructure focused on auto-immune disease and pediatric diseases in Canada; and a Business Development function, which works to maintain its product pipeline. The Company's flag products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an allergy medication. The Company provides products for the healthcare professionals and patients.
Health Drugs Pharmaceutical Pharmaceutical Industry In China Allergy Cnx Nifty Immunosuppressants Pharmaceutical Business Sector Rheumatoid Arthritis

Is MDP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.08
52 Week Low 3.25
Average Volume 7,222
200-Day Moving Average 4.112
50-Day Moving Average 3.781
20-Day Moving Average 3.661
10-Day Moving Average 3.687
Average True Range 0.215
ADX 17.98
+DI 24.394
-DI 22.596
Chandelier Exit (Long, 3 ATRs ) 3.405
Chandelier Exit (Short, 3 ATRs ) 3.895
Upper Bollinger Band 3.952
Lower Bollinger Band 3.369
Percent B (%b) 1.0
BandWidth 15.910
MACD Line -0.013
MACD Signal Line -0.037
MACD Histogram 0.0238
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.595
Resistance 3 (R3) 4.523 4.237 4.488
Resistance 2 (R2) 4.237 4.072 4.273 4.452
Resistance 1 (R1) 4.093 3.971 4.165 4.165 4.416
Pivot Point 3.807 3.807 3.843 3.843 3.807
Support 1 (S1) 3.663 3.642 3.735 3.735 3.484
Support 2 (S2) 3.377 3.541 3.413 3.448
Support 3 (S3) 3.233 3.377 3.413
Support 4 (S4) 3.305